News - BioPharm International



AstraZeneca Board Rejects Latest Pfizer Offer

May 2, 2014

AstraZeneca rejects $106 billion offer; Pfizer states its case for the merger with British government.

USP Proposes New Standards for Organic Impurities in Medicines

May 1, 2014

USP releases new and revised standards for organic impurities in medicines for public comment.

Agenus Collaborates with Merck for Novel Checkpoint Antibody-Based Cancer Immunotherapies

April 30, 2014

Agenus and Merck work together to advance immune-oncology programs.

Bristol-Myers Squibb Acquires iPierian

April 30, 2014

BMS acquisition of iPierian advances BMS' pursuit of therapeutics for genetically defined diseases.

EMA Publishes Annual Report

April 30, 2014

The European Medicines Agency's Annual Report highlights the agency's drug approvals, projects, and initiatives for 2013.

ISPE Announces Drug Shortages Prevention Plan

April 28, 2014

ISPE drug shortage prevention plan to address organizational strategies, manufacturing and quality systems, and supply chain quality.

Novartis and GSK Trade Assets

April 22, 2014

Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.

Lilly to Acquire Novartis Animal Health

April 22, 2014

Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.

Mallinckrodt to Acquire Questcor Pharmaceuticals

April 16, 2014

Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.



Click here